Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3435 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Teva launches generic Protonix tablets

As one of the first companies to file an abbreviated new drug application containing a paragraph IV certification for this product, Teva said that it has been awarded

AMDL closes private offering

The shares of AMDL common stock were sold at $3.09 per share and the four-year warrants included in the units are exercisable at $4.74 per share. Warrants to